• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Cobarrubias Fabiloa was granted 4,101 shares, increasing direct ownership by 19% to 25,184 units (SEC Form 4)

    5/21/25 5:06:12 PM ET
    $PRA
    Property-Casualty Insurers
    Finance
    Get the next $PRA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    COBARRUBIAS FABILOA

    (Last) (First) (Middle)
    100 BROOKWOOD PLACE

    (Street)
    BIRMINGHAM AL 35209

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    PROASSURANCE CORP [ PRA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/21/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/21/2025 A(1) 4,101 A $23.16 25,184 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. These shares are awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan and are exempt under Rule 16b-3. This grant was recommended by the Compensation Committee, which is composed entirely of independent directors (as disclosed on page 14 of our 2025 Proxy Statement) and was approved by our Board of Directors at its meeting on May 21, 2025. This year, the recommended and approved stock compensation grant was for shares having a value not to exceed $95,000. The number of whole shares was determined using the closing price of a share of stock on the New York Stock Exchange (NYSE) on the day of the Board of Directors meeting following the Annual Meeting of Shareholders. The NYSE closing price on May 21, 2025 was $23.16, resulting in a distribution to each non-management director of 4,101 shares.
    Remarks:
    Lee M. Pope, with Power of Attorney for the Reporting Person 05/21/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRA

    DatePrice TargetRatingAnalyst
    4/10/2025Mkt Perform → Underperform
    Raymond James
    4/3/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    11/11/2024$18.00Overweight → Neutral
    Piper Sandler
    2/24/2023$21.00Neutral
    Janney
    8/10/2021$23.00 → $26.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $PRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Rand Edward Lewis Jr exercised 29,666 shares at a strike of $23.15 and covered exercise/tax liability with 12,564 shares, increasing direct ownership by 7% to 252,516 units (SEC Form 4)

      4 - PROASSURANCE CORP (0001127703) (Issuer)

      5/27/25 12:12:59 PM ET
      $PRA
      Property-Casualty Insurers
      Finance
    • Executive Vice-President Lisenby Jeffrey Patton exercised 7,686 shares at a strike of $23.15 and covered exercise/tax liability with 3,256 shares, increasing direct ownership by 5% to 88,344 units (SEC Form 4)

      4 - PROASSURANCE CORP (0001127703) (Issuer)

      5/27/25 12:12:49 PM ET
      $PRA
      Property-Casualty Insurers
      Finance
    • Chief Financial Officer Hendricks Dana S exercised 7,686 shares at a strike of $23.15 and covered exercise/tax liability with 3,256 shares, increasing direct ownership by 14% to 35,669 units (SEC Form 4)

      4 - PROASSURANCE CORP (0001127703) (Issuer)

      5/27/25 12:12:38 PM ET
      $PRA
      Property-Casualty Insurers
      Finance